Belgian Thyroid club

2006

Third Trimester

Program :

 

Kuijt WJ et al:

Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal.

Journal of Clinical Endocrinology and Metabolism 90: 6123-6125, 2006 (comments by AVDB)

Christoffolete MA et al:

Atypical expression of Type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism.

Endocrinology 147: 1735-1743, 2006 (comments by DG)

Carella C et al:

Serum thyrotropin receptor antibodies (TRAb) concentrations in patients with Graves’ disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of TRAb and/or thyroid response modify during the observation period.

Thyroid 16: 295-302, 2006 (comments by DG)

Vigersky RA et al:

Metformin may inhibit thyrotropin (TSH) secretion in patients with hypothyroidism treated with thyroxine.

Journal of Clinical Endocrinology and Metabolism 91: 225-227, 2006 (comments by DG)

Negro R et al:

Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications.

Journal of Clinical Endocrinology and Metabolism 91: 2587-2591, 2006 (editorial by DG)

Hiraiwa T et al:

Restriction of dietary iodine does not ameliorate the early effect of antithyroid drug therapy for Graves’ disease in an area of excessive iodine intake.

Journal of Endocrinological Investigation 29: 380-384, 2006 (comments by DG)

Rhoden KJ et al:

RET/papillary thyroid cancer rearrangement in non neoplastic thyrocytes: follicular cells of Hashimoto’s thyroiditis share low-level recombination events with a subset of papillary carcinoma.

Journal of Clinical Endocrinology and Metabolism 91: 2414-2423, 2006 (comments by DG)

Olubowale O et al:

Optimization of thyroxine replacement therapy after total or near-total thyroidectomy for benign thyroid disease.

British Journal of Surgery 93: 57-60, 2006 (comments by MB)

Schmidt M et al:

Incidence of postradioiodine immunogenic hyperthyroidism (Graves’ disease) in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.

Thyroid 16: 281-288, 2006 (comments by DG)

Hunt JL et al:

Fractional allelic loss of tumor suppressor genes identifies malignancy and predicts clinical outcome in follicular thyroid tumors.

Thyroid 16: 643-649, 2006 (comments by DG)